84 related articles for article (PubMed ID: 9507530)
1. Tunicamycin in combination with retinoic acid synergistically inhibits cell growth while decreasing palmitoylation and enhancing retinoylation of proteins in the human breast cancer cell line MCF-7.
Takahashi N; Iwahori A; Breitman TR; Fukui T
Oncol Res; 1997; 9(10):527-33. PubMed ID: 9507530
[TBL] [Abstract][Full Text] [Related]
2. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
Takahashi N; Sausville EA; Breitman TR
Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation.
Kim KN; Pie JE; Park JH; Park YH; Kim HW; Kim MK
J Nutr Biochem; 2006 Jul; 17(7):454-62. PubMed ID: 16443354
[TBL] [Abstract][Full Text] [Related]
4. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
6. Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80.
Takahashi N; Breitman TR
Arch Biochem Biophys; 1994 Oct; 314(1):82-9. PubMed ID: 7944409
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.
Wang Y; He QY; Chen H; Chiu JF
Exp Cell Res; 2007 Jan; 313(2):357-68. PubMed ID: 17098229
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
9. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
Pratt MA; Niu MY; Renart LI
Apoptosis; 2006 Apr; 11(4):589-605. PubMed ID: 16528475
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells.
Marth C; Daxenbichler G; Dapunt O
J Natl Cancer Inst; 1986 Dec; 77(6):1197-202. PubMed ID: 3099046
[TBL] [Abstract][Full Text] [Related]
11. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
Takahashi N; De Luca LM; Breitman TR
Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
[TBL] [Abstract][Full Text] [Related]
12. Potential applications of cytodifferentiation therapy in hematologic malignancies.
Breitman TR; Chen ZX; Takahashi N
Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
[TBL] [Abstract][Full Text] [Related]
13. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling.
Donato LJ; Noy N
Cancer Res; 2005 Sep; 65(18):8193-9. PubMed ID: 16166294
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
15. Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells.
Fontana JA; Mezu AB; Cooper BN; Miranda D
Cancer Res; 1990 Apr; 50(7):1997-2002. PubMed ID: 2317788
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
Witters LM; Witkoski A; Planas-Silva MD; Berger M; Viallet J; Lipton A
Oncol Rep; 2007 Feb; 17(2):465-9. PubMed ID: 17203189
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic retinoic acid-binding protein in retinoic acid-resistant human breast cancer sublines.
Lacroix A; L'Heureux N; Bhat PV
J Natl Cancer Inst; 1984 Oct; 73(4):793-800. PubMed ID: 6090748
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma.
Lingen MW; Polverini PJ; Bouck NP
Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093
[TBL] [Abstract][Full Text] [Related]
20. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
